Skip to content

BREHOPHAR

Active Private limited companyfounded 2006active for 19 yearsVrijgeweidestraat 3, 8020 OostkampKBO/BCE: BE 0885.849.827 subsidiary of

Lifetime

19 annual accounts with figures on one time axis
peak of €156,611 in 2022
€122,663▲ 2.7%
lowest -€122,909 in 2017
€63,111▼ 6.6%
peak of €487,049 in 2022
€183,907▼ 16.7%
€591,174▼ 10.8%
peak of 0.5 FTE in 2007
-not published
Board1 name since 2016
1 director
Owners
100%
Documentsfilings and deeds
27-07-20264 days before the deadline
2025abbreviated format
Dividend €100,000Equity from €220,796 to €183,907Cash from €317,747 to €93,789

Key points

from the 2025 annual accounts

Equity

€183,907 from €487,049 in 2022

Equity fell by 62% in 3 years.

Debts

€591,174 76% of the balance sheet
Financial debts 45%Suppliers 24%Taxes and wages 0%Other 31%

€192,091 of the debts are secured on the company's own assets. In 2021 that was €293,438.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Three of the last ten came late. The 2019 accounts came in latest, 17 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,609 companies had the same profile as BREHOPHAR has now. Each dot stands for 7 companies, two years later.

96.8%
were still trading
2.1%
stopped another way
1.0%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,609 companies, not a prediction for BREHOPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 24-10-2016
  • 100%score equity €512,635 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0885849827
Environmental permit granted Change of use · decided by Oostkamp
1 director appointed, 1 reappointment reappointed as director · acts as permanent representative · appointed as successor director · General meeting of 14-03-2023 · Gazette deed
Company renamed from VICOO to Brehophar Registered office moved within Oostkamp · The registered office moved from Torhoutsestraat 293A, 8020 Oostkamp (Ruddervoorde) to Vrijgeweidestraat 3, 8020 Oostkamp · resigns as statutory manager · General meeting of 18-12-2017 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
BREHOPHAR Oostkamp €775,082 €122,663 23.7% -
APOTHEEK LEUPE Tielt €738,801 €117,578 19.2% -
UNIPHARM Veurne €716,027 €128,221 51.6% 1.5
APOTHEEK LIEVE TRUYEN Bree €828,441 €124,452 60.0% -
Brukom Farma Sint-Pieters-Leeuw €846,373 €129,721 37.6% -
APOTHEEK op OVERSCHELDE Wetteren €745,559 €138,865 74.8% 1.5
PHARMACIE LECOMPT Quaregnon €701,179 €132,330 5.7% -

These companies have the same main activity as BREHOPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €701,000 and €846,000, founded between 2005 and 2007.

Official details

Source: KBO
Status
Active since 21-12-2006Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.326.834.5158020 Oostkamp, registered on 20-12-2017
Financial year end
31 December
Peppol
Reachable since 15-12-2025
Company details

Annual accounts 2025

≈ €580,000estimated
€775,082▼ 12.3%
Filing
Filed on 27-07-2026, 4 days before the end of the filing period
Financials

Insights on BREHOPHAR

BREHOPHAR files the abbreviated format. That format states no turnover. The gross margin rose from €75,911 in 2007 to €122,663 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BREHOPHAR

What is the company number of BREHOPHAR?
The company number of BREHOPHAR is 0885.849.827. The VAT number is the same number with BE in front: BE 0885.849.827.
Where is BREHOPHAR based?
The registered office is at Vrijgeweidestraat 3, 8020 Oostkamp.Company details
What does BREHOPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of BREHOPHAR?
BREHOPHAR is a private limited company (BV).
When was BREHOPHAR founded?
BREHOPHAR was founded on 21-12-2006.
Is BREHOPHAR still active?
Yes, BREHOPHAR is an active enterprise in the KBO register.
What is the turnover of BREHOPHAR?
The turnover in financial year 2025 is about €580,000. This figure is estimated from the gross margin of €122,663 and 43 comparable companies (NACE 477). It probably lies between €380,000 and €1.2m.Financials
Is BREHOPHAR profitable?
In financial year 2025, BREHOPHAR made a profit of €63,111.
Where can I find the annual accounts of BREHOPHAR?
BREHOPHAR filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BREHOPHAR due?
BREHOPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.